# FTIH of ECC5004 in Healthy and Diabetic Participants

> **NCT05654831** · PHASE1 · COMPLETED · sponsor: **Eccogene** · enrollment: 69 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Placebo
- **DRUG:** ECC5004

## Key facts

- **NCT ID:** NCT05654831
- **Lead sponsor:** Eccogene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-11-01
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2024-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05654831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05654831, "FTIH of ECC5004 in Healthy and Diabetic Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05654831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*